Pipili

O le R&D a Sorrento o loʻo taulaʻi i le faʻauluina o mea fou i le COVID-19, togafitiga o le kanesa, pulea atoatoa o tiga ma faʻamaʻi autoimmune.

Polokalama Autu Faʻaaliga Muamua Vaega I Vaega II Vaega III/Pivotal FDA faamaoniga
Polokalama COVID-19  

COVISTIX™ (su'esu'e) Su'ega Antigen vave

*

Fa'atonuga mo Fa'alavelave Fa'afuase'i (EUA) i Mekisiko (COFEPRIS), Pasila (ANVISA), ma le CE Fa'ailoga i Europa

COVIMARK™ (su'esu'e) Su'ega Antigen vave

*

Talosaga na tu'uina atu i le US ma Kanata mo Fa'atonu Fa'alavelave Fa'afuase'i (EUA)

COVISHIELD™ (togafitiga) Fa'amama le Antibody (IN) i gasegase i fafo ma ma'i i totonu

40%*

COVISHIELD™ (togafitiga) Fa'ate'aina le Antibody (IV) i gasegase i fafo ma ma'i i totonu

20%*

FUJOVEE™ (Abivertinib) Tuga COVID-19 ile ICU ma'i

82%*

Fa'ata'ita'iga Taua o lo'o Fa'atali le Fa'amama a le FDA

OQORY™ (COVI-MSC) ARDS ona ole COVID-19 ile ICU

82%*

Fa'amasinoga Taua i Pasila

Mfuafuaina Taofi (pili tautala) Aneti-viral

40%*

Omicron mRNA tui vasine

20%*

Polokalama Autu Faʻaaliga Muamua Vaega I Vaega II Vaega III/Pivotal FDA faamaoniga
immunotherapy  

FUJOVEE™ (Abivertinib) NSCLC

82%*

FUJOVEE™ (Abivertinib) B Cell Lymphomas

60.2%*

FUJOVEE™ (Abivertinib) Poto

20%*

FUJOVEE™ (Abivertinib) Lupus

20%*

FUJOVEE™ (Abivertinib) MS

20%*

FUJOVEE™ (Abivertinib) GvHD

20%*

PD-L1 (Socazolimab)* SCLC

82%*

*I le Paaga ma Lee's Pharm i Saina

PD-L1 (STI-3031)** Kanesa Cervical

82%*

**I Amerika ma faipaaga ma ImmuneOncia i Korea

CD47 Tumua mautu

40%*

CD38 DAR-T Umiloma Tele

40%*

CD38 ADC Amyloidosis, Multiple Myeloma, T-ALL, ma le esophageal

40%*

TROP2 ADC* Tumua mautu

40%*

* I Saina

Seprehvec™ oncolytic virus Tumors Malosi; CNS Tumors

40%*

BCMA ADC Tula sua

20%*

Bevacizumab-ADNAB™ Endometrial Kanesa

40%*

Faʻatasi ma Mayo Clinic

Bevacizumab-ADNAB™ Ovarian Kanesa

40%*

Faʻatasi ma Mayo Clinic

Rituximab-ADNAB™ Lymphomas sela B

40%*

Faʻatasi ma Mayo Clinic
Polokalama Autu Faʻaaliga Muamua Vaega I Vaega II Vaega III/Pivotal FDA faamaoniga
tiga  

ZTlido™ 1.8%
Neuralgia Postherpetic - PHN

99.8%*

SP-102 (SEMDEXA) Lumbar Radicular/Sciatica tiga

82%*

SP-103 (Lidocaine Topical System 5.4%) Paʻu I tua

20%*

SP-104 (Naltrexone Fa'atuai Pa'u Maualalo Dose) Fibromyalgia

20%*

RTX (resiniferatoxin)
tui epidural
Tiga e le mafai ona togafitia i le Kanesa Maualuga

60.3%*

Fa'ailoga matuaoti

RTX (resiniferatoxin)
Auala i totonu o le tino
Fa'atauva'a i le Tugā Tuli OA tiga

60.2%*

Polokalama Autu Faʻaaliga Muamua Vaega I Vaega II Vaega III/Pivotal FDA faamaoniga
Fa'aolaina Lymphatic  

Sofusa® tetee i le TNF Autoimmune (RA)

40%*

Sofusa® anti-PD-1 Lymphoma T-Cell Pa'u (CTCL)

40%*

Sofusa® anti-CTLA-4 Melanoma

40%*

Faʻatasi ma Mayo Clinic
Polokalama COVID-19
Polokalama Autu (Fa'ailoga) Vaega
COVISTIX™ (su'esu'e) FDA EUA
COVIMARK™ (su'esu'e) FDA EUA
COVISHIELD™ (togafitiga) PH I
COVISHIELD™ (togafitiga) Muamua
FUJOVEE™ (Abivertinib) Ph III
OQORY™ (COVI-MSC) Ph III
Mpro Inhibitor (pili tautala) (anti-viral) Ph I
Omicron mRNA tui (tui) Muamua
immunotherapy
Polokalama Autu (Fa'ailoga) Vaega
FUJOVEE™ (Abivertinib) (NSCLC) Ph III
FUJOVEE™ (Abivertinib) (B Cell Lymphomas) Ph II
FUJOVEE™ (Abivertinib) (Prostate) Muamua
FUJOVEE™ (Abivertinib) (Lupus) Muamua
FUJOVEE™ (Abivertinib) (MS) Muamua
FUJOVEE™ (Abivertinib) (GvHD) Muamua
PD-L1 (Socazolimab)*(SCLC) Ph III
PD-L1 (STI-3031)** (Kanesa Fa'a'au'au) Ph III
CD47 (Tuma Malosi) Ph I
CD38 DAR-T (Multiple Myeloma) Ph I
CD38 ADC (Amyloidosis, Multiple Myeloma, T-ALL, ma le esophageal) Ph I
TROP2 ADC* (Tuma Malosi) Ph I
Seprehvec™ oncolytic virus (Tumo Malosi; Pumo CNS) PH I
BCMA ADC (Tumo Suava) Muamua
Bevacizumab-ADNAB™ (Kanesa Fa'ama'i) Ph I
Bevacizumab-ADNAB™ (Kanesa Ovarian) Ph I
Rituximab-ADNAB™ (B-cell Lymphomas) Ph I
tiga
Polokalama Autu (Fa'ailoga) Vaega
ZTlido™ 1.8% (Postherpetic Neuralgia - PHN) FDA faamaoniga
SP-102 (SEMDEXA) Ph III
SP-103 (Lidocaine Topical System 5.4%) Muamua
SP-104 (Naltrexone Fa'atuai Pa'u Maualalo Dose) Muamua
RTX (resiniferatoxin) tui epidural (Tiga Fa'aletonu ile Kanesa Maualuga) Ph II
RTX (resiniferatoxin) Auala i totonu o le tino (Fa'alegata i le Tugā OA Tu'itu'i tiga) Ph II
Fa'aolaina Lymphatic
Polokalama Autu (Fa'ailoga) Vaega II
Sofusa® tetee i le TNF (Autoimmune RA) Ph I
Sofusa® anti-PD-1 (Cutaneous T-Cell Lymphoma (CTCL)) Ph I
Sofusa® anti-CTLA-4 (Melanoma) Ph I